We use cookies to ensure our website works properly and to personalise your experience. Cookies policy
1Asst.Prof, Dept of Pharmacology, Vijaya institute of pharmaceutical sciences for women, Vijayawada.
2Pharm.D 4thyr Student, Srinivasarao College of Pharmacy, Visakhapatnam.
3Pharm.D 4thyr Student, Srinivasarao College of Pharmacy, Visakhapatnam.
4Pharm.D 4thyr Student, Srinivasarao College of Pharmacy, Visakhapatnam.
Poliomyelitis is a highly contagious disease caused by a virus belonging to the PICORNAVIRIDAE family. Post-polio syndrome survives paralytic poliomyelitis and is characterized by a neuromuscular symptom complex that leads to impaired physical function. To systematically review the effect of any treatment on post-polio syndrome compared with placebo, usual care or no treatment. Post-polio syndrome is characterized by a worsening of existing or new health problems, most commonly muscle weakness and fatigue, general fatigue, and pain after a period of stability following an acute post-polio infection. Patients with post-polio syndrome should be advised to avoid both inactivity and overloading of weak muscles.
Ch. Lochana, S. Niharika, K. Hemalatha, K. Supriya, Megha T. Salve, Poliomyelitis, Int. J. in Pharm. Sci., 2023, Vol 1, Issue 12, 937-948. https://doi.org/10.5281/zenodo.10443866
10.5281/zenodo.10443866